Craft

Roche

Stock Price

CHF276.3

2024-10-29

Market Capitalization

CHF223.1 B

2024-10-29

Revenue

CHF61.5 B

FY, 2025

Roche Summary

Company Summary

Overview
Roche Holding is a biotech company that provides in vitro diagnostics and supplies services. It operates through two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals division offers products for treating eye diseases, sclerosis, hemophilia A, cancer, rheumatoid arthritis, lung diseases, COVID-19, etc. The Diagnostics division produces immunodiagnostic products, clinical chemistry tests, and staining solutions.
Type
Public
Status
Active
Founded
1896
HQ
Basel, CH | view all locations
Website
https://www.roche.com/
Cybersecurity rating
ESG rating
60-79 out of 100|View all ESG data
Sectors

Key People

  • Thomas Schinecker

    Thomas Schinecker, Chief Executive Officer

  • Teresa Graham

    Teresa Graham, CEO Roche Pharmaceuticals

  • Matt Sause

    Matt Sause, CEO Roche Diagnostics

  • Alan Hippe

    Alan Hippe, Chief Financial Officer

Operating MetricsView all

New Molecular Entities in Clinical Development

82
5.7%

FY, 2023

Patients Included in Clinical Trials

303.9K
13.6%

FY, 2023

Tests Conducted (Diagnostics Products)

29.2B

FY, 2023

LocationsView all

144 locations detected

  • Basel, Basel-Stadt HQ

    Switzerland

    124 Grenzacherstrasse

  • Boston, MA

    United States

    80 Guest St

  • Cambridge, MA

    United States

    150 Second St

  • Indianapolis, IN

    United States

    9115 Hague Rd

  • Little Falls, NJ

    United States

    150 Clove Rd, 8th Floor

  • New York, NY

    United States

    233 Spring St

and 138 others

Roche Financials

Summary Financials

Revenue (FY, 2025)
CHF61.5B
Gross profit (FY, 2025)
CHF50.5B
Net income (FY, 2025)
CHF13.8B
Cash (FY, 2025)
CHF5.6B
EBIT (FY, 2025)
CHF18.5B
Enterprise value
$250.7B

Footer menu